What is ABOS's current stock price?

As of now, ABOS is trading at $1.06, with a daily change of +17.67%.

What are ABOS stock strengths?

ABOS strengths include Earnings are forecast to grow, .

What are the risks associated with ABOS stock?

ABOS Key risk is its Moderate Risk Level, .

What is ABOS next earnings date?

ABOS next earnings report is scheduled for May 12, 2025.

What is ABOS's current stock rating?

ABOS's current stock rating is Sell.

Should I buy ABOS stock right now?

Based on the current rating of Sell, it is advisable to consider Sell as your next step with ABOS stock.

Is ABOS a Strong Buy right now?

ABOS's current stock rating is Sell, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for ABOS?

A 'Strong Buy' rating for ABOS indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for ABOS?

A 'Strong Sell' rating for ABOS suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence ABOS's stock rating?

ABOS's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Acumen Pharmaceutica (ABOS) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

ABOS

Acumen Pharmaceutica

$1.06

+$0.16 | +17.67%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

Open

$ 0.87

MKT CAP

$ 64.87M

High

$ 1.07

VOL

$ 326.14K

Low

$ 0.86

AVG VOL

$ 234.20K

Chart

1.28

1.6

2.25

3.56

1year

6month

3month

1month

ABOS Latest Headlines +

Top 3 Materials Stocks Which Could Rescue Your Portfolio For April. The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator which compares a stock’.s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’.s price action it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI

Tue Apr 15, 2025

Activity

Momentum

Potential

Technical

Blanchard® Wins Two 2025 Intrepid Momentum Awards. Celebrating Innovative Digital Learning Experiences SAN DIEGO April 14 2025 /PRNewswire/ -- Blanchard® a global pioneer in leadership development consulting and coaching for more than 45 years has been recognized with two Intrepid Momentum Awards for its Business Acumen Foundations...

Mon Apr 14, 2025

Activity

Telos Corporation Awarded $5.8M Contract to Support Defense Departments Microwave Line of Sight Program. ASHBURN Va. April 10 2025 (GLOBE NEWSWIRE) -- (NASDAQ:) a leading provider of cyber cloud and enterprise security solutions for the world'.s most security-conscious organizations today announced it has been awarded a $5.8 million contract to provide Field Service Representative (FSR) support and technical expertise for the United States Department of Defense'.s Microwave Line of Sight

Thu Apr 10, 2025

Activity

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting. Biomarker results from Phase 1 INTERCEPT-AD trial of sabirnetug in patients with early Alzheimers disease recently published in The Journal of Prevention of Alzheimers Disease

Wed Apr 2, 2025

Activity

INE Security Alert: Building the Resilient Cybersecurity Resume. Cary NC April 01 2025 (GLOBE NEWSWIRE) -- The cybersecurity field remains a beacon of opportunity amid economic uncertainty but it demands skilled professionals. INE Security a leader in cybersecurity training and certifications is addressing the critical need for skilled operators by equipping them with the tools to not only survive but thrive in a landscape defined by constant evolution and talent shortages.".The cybersecurity

Tue Apr 1, 2025

Activity

Potential

Explore our ABOS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABOS Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABOS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

ABOS

Acumen Pharmaceutica

$1.06

+$0.16 | +17.67%

Chart

1.28

1.6

2.25

3.56

1year

6month

3month

1month

Discover ABOS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABOS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABOS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABOS Stock trends

ABOS Stock performance

ABOS Stock analysis

ABOS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

ABOS Stock Analysis for the Last 90 Days

ABOS Risk Level

ABOS Analysts Opinion

ABOS Street Consensus

ABOS Performance Sentiment

Technical Price Levels

ABOS Financial Health

Explore our ABOS Stock insights

Receive our ABOS Daily Alerts

ABOS Stock Analysis for the Last 90 Days

ABOS Street Consensus

Technical Price Levels

Discover ABOS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABOS. We're here to help you make informed investment decisions today.

Receive our ABOS Daily Alerts